Visual

Thallion Pharmaceuticals Inc. is a biotechnology company focussed on developing new treatments for under-served markets in oncology and infectious disease.

Events

October 21 - 24, 2008

Poster Presentation at the EORTC-NCI-AACR 2008 Conference

October 14, 2008

2008 Q3 Earnings Announcement and Webcast

›› more

News

December 10, 2008

Thallion Announces a Review of Strategic Alternatives

November 18, 2008

Thallion Initiates Enrollment in Phase II Metastatic Melanoma Trial

October 24, 2008

Thallion's TLN-4601 Inhibits Mutated K-RAS Signaling in Cancer Cells

›› archives